Sugi Predict

Sugi Predict / Compounds / SCHEMBL29437930

SCHEMBL29437930

SCHEMBL29437930

CC(C)C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)O)C(C)C

nearest known ligand 0.65

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ C5AR1 P21730 2/20 0.65
▸ NMBR P28336 2/20 0.60
▸ GRPR P30550 2/20 0.60
▸ GLP1R P43220 9/20 0.54
▸ GCGR P47871 3/20 0.54
▸ CXCR4 P61073 2/20 0.51
▸ MC4R P32245 1/20 0.51
▸ GNRHR P30968 1/20 0.51
▸ GALR2 O43603 1/20 0.51
▸ GALR1 P47211 1/20 0.51
▸ GIPR P48546 6/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30477482 0.97 C5AR1 (0.64) C5AR1NMBRGRPRGLP1RGCGR
SCHEMBL30906528 0.87 GLP1R (0.63) C5AR1GLP1RGCGR
SCHEMBL31182561 0.86 GLP1R (0.68) NMBRGRPRGLP1RGCGRGIPR
SCHEMBL30431758 0.85 C5AR1 (0.69) C5AR1NMBRGRPRGLP1RGCGR
SCHEMBL30518053 0.85 C5AR1 (0.65) C5AR1NMBRGRPR
SCHEMBL31670621 0.84 CTSL (0.56) C5AR1NMBRGRPRGLP1RGCGR
SCHEMBL30518080 0.84 NTSR2 (0.65) C5AR1NMBRGRPRCXCR4
SCHEMBL30382749 0.84 C5AR1 (0.59) C5AR1NMBRGRPR
SCHEMBL31670652 0.83 F2 (0.51) C5AR1NMBRGRPRMC4R
SCHEMBL31622296 0.83 C5AR1 (0.71) C5AR1CXCR4MC4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230321241-A1 CANCER PEPTIDE VACCINE AND METHOD OF PREPARING THE SAME BRIGHTPATH BIOTHERAPEUTICS CO., LTD. (JP) 2023-10-12 — — US claimed
CN-116261450-A Cancer peptide vaccine and preparation method thereof 亮径生物疗法有限公司 2023-06-13 — — CN claimed
WO-2023013755-A1 CANCER PEPTIDE VACCINE COCKTAIL FORMULATION AMD METHOD FOR PRODUCING SAME ブライトパス・バイオ株式会社 2023-02-09 — — WO claimed
WO-2022025093-A1 CANCER PEPTIDE VACCINE AND METHOD FOR PRODUCING SAME ブライトパス・バイオ株式会社 2022-02-03 — — WO claimed
US-20230321241-A1 CANCER PEPTIDE VACCINE AND METHOD OF PREPARING THE SAME BRIGHTPATH BIOTHERAPEUTICS CO., LTD. (JP) 2023-10-12 — — US disclosed
US-20230321241-A1 CANCER PEPTIDE VACCINE AND METHOD OF PREPARING THE SAME BRIGHTPATH BIOTHERAPEUTICS CO., LTD. (JP) 2023-10-12 — — US disclosed
CN-116261450-A Cancer peptide vaccine and preparation method thereof 亮径生物疗法有限公司 2023-06-13 — — CN disclosed
CN-116261450-A Cancer peptide vaccine and preparation method thereof 亮径生物疗法有限公司 2023-06-13 — — CN disclosed
WO-2023013755-A1 CANCER PEPTIDE VACCINE COCKTAIL FORMULATION AMD METHOD FOR PRODUCING SAME ブライトパス・バイオ株式会社 2023-02-09 — — WO disclosed
WO-2022025093-A1 CANCER PEPTIDE VACCINE AND METHOD FOR PRODUCING SAME ブライトパス・バイオ株式会社 2022-02-03 — — WO disclosed
WO-2022025093-A1 CANCER PEPTIDE VACCINE AND METHOD FOR PRODUCING SAME ブライトパス・バイオ株式会社 2022-02-03 — — WO disclosed
Send feedback